| Metric | Q2 2025 | Q1 2025 | Q2 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $111M | $109M | $109M | 1.7% | 1.7% |
| Op. Income | $13M | -$5M | $13M | 357.7% | 3.6% |
| Gross Margin | 18.7% | 4.1% | 17.5% | 14.6pp | 1.2pp |
| Net Margin | 9.4% | -3.7% | 9.3% | 13.0pp | 0.1pp |
| EPS (Diluted) | $0.71 | $-0.30 | $0.73 | 336.7% | -2.7% |
| Free Cash Flow | $7M | $2M | $14M | 192.1% | -50.9% |
| Item | Amount |
|---|---|
| REVENUE | $111M |
| Cost of Revenue | $90M |
| GROSS PROFIT | $21M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $8M |
| SG&A Expenses | $8M |
| Other Expenses | $0 |
| Operating Expenses | $8M |
| Cost & Expenses | $97M |
| OPERATING INCOME | $13M |
| Interest Income | $0 |
| Interest Expense | $3M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $13M |
| Income Tax Expense | $3M |
| Net Income from Continuing Ops | $10M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $10M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $10M |
| D&A | $1M |
| EBIT | $13M |
| EBITDA | $15M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $111M |
| Cost of Revenue | $90M |
| GROSS PROFIT | $21M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $8M |
| SG&A Expenses | $8M |
| Other Expenses | $0 |
| Operating Expenses | $8M |
| Cost & Expenses | $97M |
| OPERATING INCOME | $13M |
| Interest Income | $0 |
| Interest Expense | $3M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $13M |
| Income Tax Expense | $3M |
| Net Income from Continuing Ops | $10M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $10M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $10M |
| D&A | $1M |
| EBIT | $13M |
| EBITDA | $15M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $10M |
| Depreciation & Amortization | $1M |
| Stock-Based Compensation | $744.0K |
| Deferred Income Tax | $2M |
| Other Non-Cash Items | $3M |
| Change in Working Capital | -$11M |
| OPERATING CASH FLOW | $7M |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$591M |
| Sales/Maturities of Investments | $575M |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$16M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$5M |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | -$5M |
| FREE CASH FLOW | $7M |
| Net Change in Cash | -$14M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $67M |
| Short-Term Investments | $1.1B |
| Net Receivables | $140M |
| Inventory | $0 |
| Other Current Assets | -$1.1B |
| TOTAL CURRENT ASSETS | $138M |
| PP&E (Net) | $9M |
| Goodwill | $5M |
| Intangible Assets | $14M |
| Long-Term Investments | $315M |
| Tax Assets | $0 |
| Other Non-Current Assets | -$315M |
| TOTAL NON-CURRENT ASSETS | $28M |
| TOTAL ASSETS | $1.7B |
| Account Payables | $3M |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | -$8M |
| TOTAL CURRENT LIABILITIES | $0 |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $1.0B |
| TOTAL NON-CURRENT LIABILITIES | $1.0B |
| TOTAL LIABILITIES | $1.0B |
| Common Stock | $0 |
| Additional Paid-In Capital | $464M |
| Retained Earnings | $265M |
| Treasury Stock | -$33M |
| Accum. Other Comp. Income | -$5M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $695M |
| Minority Interest | $0 |
| TOTAL EQUITY | $695M |
| TOTAL LIABILITIES & EQUITY | $1.7B |
| Total Debt | $9M |
| Net Debt | -$58M |
